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OxoferinThis study demonstrates that heme peroxidases from different superfamilies react differently with chlorite. In
contrast to plant peroxidases, like horseradish peroxidase (HRP), themammalian counterpartsmyeloperoxidase
(MPO) and lactoperoxidase (LPO) are rapidly and irreversibly inactivated by chlorite in the micromolar concen-
tration range. Chlorite acts as efﬁcient one-electron donor for Compound I and Compound II of MPO and LPO and
reacts with the corresponding ferric resting states in a biphasic manner. The ﬁrst (rapid) phase is shown to
correspond to the formation of a MPO-chlorite high-spin complex, whereas during the second (slower) phase
degradation of the prosthetic group was observed. Cyanide, chloride and hydrogen peroxide can block or delay
heme bleaching. In contrast to HRP, the MPO/chlorite system does not mediate chlorination of target molecules.
Irreversible inactivation is shown to include hemedegradation, iron release and decrease in thermal stability. Dif-
ferences betweenmammalian peroxidases and HRP are discussedwith respect to differences in active site archi-
tecture and heme modiﬁcation.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Chlorite (−OClO) reacts with a variety of different heme containing
enzymes. For example, it was shown to induce the formation of methe-
moglobin [1] and might act as hydroxylating agent in cytochrome P450
[2]. However, detailed mechanistic studies are only available for two
classes of heme enzymes, namely chlorite dismutases and peroxidases.
Chlorite dismutases are found in bacteria and archaea [3,4] and convert
chlorite to chloride (Cl−) and dioxygen (O2) with hypochlorous acid
(HOCl) as proposed reaction intermediate [5]. During this conversion
a covalent O\O bond is formed, a reaction which was so far only ob-
served at photosystem II of oxygenic phototrophic organisms.
Amonghemeperoxidases, chloritewas shown to beutilized by cyto-
chrome c peroxidase [6], chloroperoxidase [7] and horseradish peroxi-
dase (HRP) [8]. Upon reaction with chlorite the enzymes produced
halogenating agents but not O2. Detailed studies were carried out by
Hager and co-workers on HRP [9–11]. Recently, by using sequential-
mixing stopped-ﬂow spectroscopy, we have reinvestigated this reac-
tion and could demonstrate that HRP mixed with chlorite follows the
whole peroxidase cycle [12]. Chlorite mediates the two-electron oxida-
tion of ferric HRP [Fe(III)…Por] to Compound I [Fe(IV) = O…Por•+]
thereby releasing hypochlorous acid (Reaction 1). Furthermore, chlorite
acts as one-electron reductant of both Compound I and Compound II+43 1 47654 6059.
er).
. This is an open access article under[Fe(IV) = O…Por] forming chlorine dioxide (•ClO2) (Reactions 2 & 3).
The HRP mediated reactions are strongly pH dependent, suggesting
that chlorous acid (HOClO) is the reacting species [12]. In addition
both reaction products alsomediate the two-electron oxidation of ferric
HRP to Compound I (Reaction4&5) but cannot serve as electrondonors
for Compounds I or II.
Fe IIIð Þ…Por½ þ−OClO→ Fe IVð Þ ¼ O…Por•þ
h i
þ HOCl=−OCl;Hþ
ðReaction1Þ
½Fe IVð Þ ¼ O…Por•þþ−OClO→½Fe IVð Þ¼ O…Porþ•ClO2 ðReaction2Þ
½Fe IVð Þ¼ O…Porþ−OClO→ Fe IIIð Þ…Por½ þ•ClO2 þH2O ðReaction3Þ
Fe IIIð Þ…Por½  þHOCl→ Fe IVð Þ ¼ O…Por•þ
h i
þ Cl− ðReaction4Þ
Fe IIIð Þ…Por½ þ•ClO2→½Fe IVð Þ ¼ O…Por•þþ•ClO: ðReaction5Þ
In thisworkwehave extended this study to humanmyeloperoxidase
(MPO) and bovine lactoperoxidase (LPO). The fact that MPO is involved
in the regulation of immune functions [13] and that commerciallythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Oxoferin and WF10 contain chlorite as the active principle [14],
prompted us to this study.
In contrast to plant-type peroxidases the heme in MPO is covalently
attached to the protein via two ester-linkages and a sulfonium ion link-
age [15]. These posttranslational modiﬁcations signiﬁcantly modify the
spectral and redox properties of this oxidoreductase, e.g. allowing MPO
to oxidize chloride to hypochlorous acid that acts as antimicrobial agent
in the innate immune system [16]. Additionally, the covalent heme to
protein bondswere proposed to protect the heme ofMPO from its high-
ly reactive reaction products [17].
Here we demonstrate that – in contrast to horseradish peroxidase
(HRP) – humanMPO and bovine LPO cannot utilize chlorite to form chlo-
rinating species [6]. Moreover, we show that both peroxidases are very
susceptible to chlorite resulting in fast loss of activity accompanied by
(almost) complete heme bleaching. We report the ﬁrst comprehensive
study of the reactions of all biological relevant redox intermediates (ferric
state, Compounds I & II) ofMPO and LPOwith chlorite and their potential
reaction products. We propose a mechanism of interaction between
chlorite and the metalloproteins, discuss the observed differences with
plant-type peroxidases as well as the biological relevance of our ﬁndings.
2. Material and methods
2.1. Reagents
Standard chemicals and biochemicals were obtained from Sigma-
Aldrich Handels GmbH (Vienna, Austria) at the highest grade available.
Hydrogen peroxide concentration was determined spectrophotometri-
cally using an extinction coefﬁcient at 240 nm of 39.4 M−1 cm−1 [18].
The concentration of sodium chlorite (Sigma, 80%) and hypochlo-
rite were determined using the extinction coefﬁcient at 260 nm of
154 M−1 cm−1 [19] and at 292 nm of 350 M−1 cm−1 [20], respec-
tively. Highly puriﬁed dimeric leukocyte myeloperoxidase of a puri-
ty index (A428/A280) of at least 0.85 was purchased as lyophilized
powder from Planta Natural Products (http://www.planta.at) and
the concentration was determined spectrophotometrically using
ε428 = 91 000 M−1 cm−1 per heme [21]. Lactoperoxidase from bo-
vine milk was purchased as a lyophilized powder (Sigma, purity
index A412/A280 = 0.9). Enzyme concentration was determined by
using the extinction coefﬁcient 112,000 M−1 cm−1 at 412 nm
[22]. Horseradish peroxidase type VIa was obtained from Sigma
and used without further puriﬁcation. An extinction coefﬁcient at
403 nm of 102,000 M−1 cm−1 [23] was used for the determination
of protein concentration. Oxovasin was obtained from NUVO
Manufacturing GmbH (Wanzleben, Germany). Essentially the
same drug is also marketed as Oxoferin™, a term more frequently
used in a scientiﬁc context, therefore we will also refer to Oxoferin
instead of Oxovasin in this study.
2.2. Preparation of chlorine dioxide
Chemically pure, chlorine free chlorine dioxide (•ClO2) solutionswere
prepared by acidiﬁcation of sodium chlorite (NaOClO) with sulfuric acid
(H2SO4) according to 4NaOClO+2H2SO4→ 2 •ClO2+HCl+ HOClO2+
2 Na2SO4 + H2O [12]. In detail, 100 mL sodium chlorite (2.5% w/w) was
acidiﬁed with 10 mL sulfuric acid (10% v/v). Sulfuric acid was added in
1 mL portions with 5 min intervals. Formed gaseous •ClO2 was removed
from the reactionﬂask by a nitrogen ﬂow, puriﬁed by bubbling through a
gas scrubbing tower containing 100 mL sodium chlorite solution
(2.5% w/w) and, ﬁnally, recovered by absorbing in 100 mL chilled deion-
izedwater in an amber reagent bottle. The concentration of •ClO2was de-
termined using an extinction coefﬁcient at 359 nm of 1230 M−1 cm−1
[24]. The obtained stock solution (≈42mM)was immediately aliquoted
in Eppendorf tubes and stored in the dark at−30 °C. After thawing the
stock solution was kept in the dark on ice and was stable for about 4 h.More diluted solutions were prepared immediately before use and the
concentrations were determined simultaneously to the measurements.
2.3. In gel activity staining
For in-gel heme stainingMPO samples (10 μg) were separated using
SDS-PAGE electrophoresis under non-reducing conditions. Gelswere in-
cubated with a mixture of 6.3 mM 3,3,5,5,-tetramethylbenzidine (TMB)
inmethanol (3parts) and 0.25M sodiumacetate at pH5.0 (7parts) for 1
h in the dark. Activity stainingwas started by adding hydrogen peroxide
at a ﬁnal concentration of 30 mM [25].
2.4. Activity assays
Monochlorodimedon (MCD) is a substrate often used to study halo-
genation reactions. Upon chlorination to dichlorodimedon (DCD) it
loses its absorbance at 290 nm [26]. Monochlorodimedon (100 μM)
and various amounts of chlorite were dissolved in 100 mM phosphate
buffer, pH 5.0, and the reaction was started by addition of MPO or LPO.
For the determination of the inhibitory effect of chlorite on the chlo-
rination activity of MPO assays contained additional hydrogen peroxide
(100 μM) and chloride (100 mM). In this case the reaction was started
either withMPO (100 nM) or hydrogen peroxide. The latter case result-
ed in a preincubation of MPO with both chloride and chlorite for 1 min.
Additionally, the inhibitory effect of chlorite on the chlorination ac-
tivity was measured by continuously monitoring hydrogen peroxide
concentration polarographically with a platinum electrode covered
with a hydrophilicmembrane and ﬁtted to the Amperometric Biosensor
Detector 3001 (Universal Sensors, Inc., U.S.A.). Again the reaction was
started by adding either MPO (100 nM) or hydrogen peroxide
(100 μM) after one minute. All reactions were performed at 25 °C.
As a furthermethod to study the inhibitory effect of chlorite onMPO
we used aminophenyl ﬂuorescein (APF) which speciﬁcally detects the
halogenating enzyme activity [27]. Brieﬂy, 10 nM MPO was pre-
incubated with 0–500 μM chlorite in phosphate buffered saline (PBS),
pH 7.4, at 37 °C for 1min. All samples also contained 10 μMAPF. The en-
zymatic activity was started by adding 25 μM H2O2 via an injector de-
vice. The HOCl-derived oxidation of APF was followed for 30 min at
37 °C by measuring the ﬂuorescence intensity at 522 nm (excitation
at 488 nm). All measurements were performed in a ﬂuorescencemicro-
plate reader Tecan Inﬁnite 200 PRO, Switzerland.
2.5. Circular dichroism and electron paramagnetic resonance spectroscopy
Circular dichroism spectra (CD) were recorded using a Chirascan CD
spectrophotometer (Applied Photophysics, UK). In the far-UV region an
enzyme concentration of 2 μMand a cuvettewith a path length of 1mm
was used. For measurements in the Soret region (300 nm–500 nm) the
enzyme concentration was 5 μM and the path length of the cuvette was
1 cm.
Samples for electron paramagnetic resonance (EPR) measurements
were prepared using 100 μMMPO in 100 mM phosphate buffer, pH 5.
After addition of chlorite in 5- and 10-fold excess, respectively, 5% glyc-
erol was added as cryoprotectant and 100 μL of the reaction solution
were immediately transferred into a quartz EPR tube (4 mm OD) and
frozen in liquid nitrogen. Before measurement, the tube was degassed
with Ar while the sample was kept frozen on dry ice.
EPR measurements were carried out at 10 K on an EMX continuous
wave (cw) spectrometer (Bruker, Germany), operating at X-band
(9 GHz) frequencies, equipped with a high sensitivity resonator and a
helium cryostat from Oxford Instruments (ESR900). EPR spectra were
recorded under non-saturating conditions using 2 mW microwave
power, 100 kHz modulation frequency, 1 mT modulation amplitude,
20 ms conversion time and 20 ms time constant and 4096 data points.
Simulations of high-spin Fe(III) spectra were carried out using the
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Fig. 1. Reaction of ferric MPO with chlorite. Assay: 2 μM MPO with 200 μM chlorite in
100 mM phosphate buffer, pH 5.0. (A) Spectral changes observed within the ﬁrst 60 ms.
Black spectrum, ferric MPO; and gray spectrum, intermediate observed after 60 ms. The
inset shows the corresponding biphasic time trace at the Soret maximum for the ﬁrst
1.5 s. (B) Continuation of reaction in (A). Gray spectrum corresponds to gray spectrum
in (A). Subsequent spectra (black) were taken at 80 ms, 170 ms, 350 ms, 710 ms, 1.5 s
and 10 s, respectively. For orientation the spectral features of ferric MPO (bold black)
are included. (C) Plot of the pseudo-ﬁrst-order rate constants against chlorite concentra-
tion for the fast phase of the reactions. (D) Plot of the pseudo ﬁrst-order rate constants
against chlorite concentration for the second slower phase.
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the individual high-spin intermediates.
2.6. Transient state kinetics
Transient-state measurements were made using the SX.18 MV
stopped-ﬂow spectrophotometer and PiStar-180 circular dichroism
spectrometer (Applied Photophysics, UK) equipped with a 1 cm obser-
vation cell. Calculation of pseudo ﬁrst-order rate constants (kobs) from
experimental time traces was performed with a SpectraKinetic work
station (Version 4.38) interfaced to the instruments. Second-order
rate constants were calculated from the slope of the linear plot of the
pseudo ﬁrst-order rate constants versus substrate concentration. To
follow spectral transitions, a Model PD.1 photodiode array accessory
(Applied Photophysics, UK) connected to the stopped-ﬂowmachine to-
gether with XScan diode array scanning software (Version 1.07) was
utilized.
2.7. Differential scanning calorimetry
Differential scanning calorimetric (DSC) measurements were per-
formed using a VP-capillary DSC microcalorimeter from Microcal (cell
volume: 137 μL), controlled by the VP-viewer program and equipped
with an autosampler for 96 well plates. Samples were analyzed using
a programmed heating scan rate of 60 °C h−1 over a temperature
range of 20 °C to 110 °C and a cell pressure of approximately 60 psi
(4.136 bar). Collected DSC data were corrected for buffer baseline and
normalized for protein concentration. The reaction conditions were: 5
μMMPO in 100mMphosphate buffer pH 5.0 in the absence or presence
of 25 μM chlorite and different incubation times. Reactions were
stopped by addition of 4 mM cysteine. Guanidinium hydrochloride
(GdnHCl; 5 mM) was added before measurements were started to
avoid non-speciﬁc protein aggregation at increasing temperatures.
Microcal origin software was used for data analysis. Heat capacity
(Cp) was expressed in kcal mol−1 K−1 (1 cal = 4.184 J). Data points
were ﬁtted to non-two-state equilibrium-unfolding models by the
Lavenberg/Marquardt (LM) non-linear least square method.
3. Results
The plant-type model peroxidase HRP is able to use chlorite instead
of hydrogen peroxide as two-electron oxidant of the ferric state, thereby
forming Compound I and hypochlorous acid [12], which is known to
chlorinate various target molecules likeMCD. In contrast, as already ob-
served by George [6], no chlorinating species could be detected in the
reaction betweenMPOwith chlorite. Upon re-evaluation of this reaction
we could conﬁrm that the system MPO/chlorite is unable to chlorinate
MCD (not shown). This signiﬁcant discrepancy between plant-type per-
oxidases and their mammalian counterparts prompted us to perform a
more comprehensive study on (i) the interaction of chlorite with all rel-
evant redox intermediates of MPO and LPO as well as on (ii) the impact
of chlorite on their structural integrity.
3.1. Reaction of ferric MPO and LPO with chlorite
Upon reaction of chlorite with ferric MPO the heme absorbance in
the Soret region rapidly decreased. Fig. 1A and B depict the spectral
changes upon addition of 200 μM chlorite to 2 μM ferric MPO at
pH 5.0. The reaction was biphasic (inset to Fig. 1A), with the ﬁrst rapid
phase (Fig. 1A) leading directly (isosbestic points at 445 nm, 490 nm,
595 nm and 660 nm) to an intermediate state within 60 ms. This state
(gray spectrum in Fig. 1A) exhibited a decreased absorbance at the
Soret maximum as well as a shoulder around 455 nm (isosbestic point
at 445 nm), which was more pronounced at higher chlorite concentra-
tions. Concomitant spectral changes at higherwavelengths in the visible
region included absorbance decrease at 570 nm and increase at 625 nm(isosbestic points at 492 and 593 nm). The second and slower phase
(Fig. 1B) was characterized by a continuous loss of absorbance in the
whole spectral region between 300 and 650 nm.
Upon ﬁtting of this biphasic reaction by using a double exponen-
tial equation apparent bimolecular rate constants were calculated.
Both phases were dependent on the concentration of chlorite.
Fig. 1C and D show the resulting plots of the respective pseudo-
ﬁrst order rate constants against substrate concentration yielding
second order rate constants of 2.3 × 105 M−1 s−1 (fast reaction)
and 1.5 × 104 M−1 s−1 (slow reaction) at pH 5.0. Both reactions
strongly depended on the pH. The second-order rate constants at
pH 4.0 were roughly one order of magnitude higher compared to
pH 5.0 (1.5 × 106 M−1 s−1 and 8.4 × 104 M−1 s−1), whereas at
pH 7.0 rate constants of 4.6 × 104 M−1 s−1 and 3.1 × 103 M−1 s−1,
respectively, were obtained.
MPO
MPO + 5-fold chlorite
MPO + 10-fold chlorite
A
B
C
Fig. 3. EPR analysis of the interaction of MPO with chlorite. Experimental cw EPR spectra
(black) and simulation (gray) of (A) 100 μM ferric MPO in 100 mM phosphate buffer,
pH 5.0, (B) 100 μMMPO after addition of 5-fold chlorite and (C) 100 μMMPO after addi-
tion of 10-fold chlorite. The spectra were recorded at 10 K and the samples contained 5%
glycerol.
13C. Jakopitsch et al. / Journal of Inorganic Biochemistry 135 (2014) 10–19Fig. 2A shows an overlay of the spectrum of 1 μM ferric MPO at pH 5
(black line) and the ﬁnal absorbance spectrum after reaction with
50 μM chlorite (gray line). Heme bleaching at the Soret band was ac-
companied by a substantial increase in absorbance in the region be-
tween 650 and 850 nm and the appearance of maxima at 700 nm and
754 nm (inset to Fig. 2A). To our knowledge these spectral features
have never been reported so far for MPO and most probably indicate
heme destruction and the formation of an inactive form similar to the
P670 species in HRP [29]. Fig. 2B shows a typical time trace of the reac-
tion of 2 μMMPOwith 1mM chlorite at pH 5.0 followed at 720 nm. The
reaction was monophasic and could be ﬁtted using a single exponential
equation and the plot of the pseudo-ﬁrst order rate constants against
chlorite concentration yielded a straight line (Fig. 2C). From the slope an
apparent second order rate constant of 4.8 × 103M−1 s−1 could be calcu-
lated. Again this reaction was pH dependent with 9.1 × 104M−1 s−1 and
1.5 × 103 M−1 s−1 at pH 4.0 and 7.0, respectively. These rate constants
were similar to those obtained for the slow phase of the biphasic reaction
depicted in Fig. 1 and might reﬂect modiﬁcation and destruction of the
prosthetic group.
In order to probe the nature of the initial binding complex (the tran-
sitionwith clear isosbestic points, Fig. 1A) between ferricMPOand chlo-
rite, EPR spectroscopy was performed. Fig. 3A shows the spectrum of
100 μMferricMPO in 100mMphosphate buffer, pH 5.0, reﬂecting a pre-
dominantly rhombically distorted high-spin formwith some small con-
tributions of less rhombicity. Similar spectra were recorded previously
[30]. Already upon preincubation ofMPOwith a very lowexcess of chlo-
rite (5-times stoichiometric excess) the rhombicity signiﬁcantly
changed, indicating a rearrangement around the heme center towards
axial symmetry (Fig. 3B). Since formation of a low-spin species was
not detected, chlorite seemed to act as high-spin ligand. This became0.00
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Fig. 2. Kinetics of heme degradation. (A) Comparison of spectral features of 1 μM ferric
MPO (black) with the spectral features obtained upon reaction of 1 μMMPO with 50 μM
chlorite (gray) at pH 5.0. (B) Time trace at 720 nm and single exponential ﬁt for the reac-
tion of 2 μMMPOwith 1mMchlorite at pH 5.0. (C) Plot of the obtained pseudo-ﬁrst-order
rate constants against chlorite concentration.further evident by preincubation of MPOwith a higher (10-fold) excess
of chlorite (Fig. 3C). Here, the rhombically distorted high-spin formsdis-
appeared almost completely leading to a predominantly axial signal.
Table 1 shows the simulation parameters of the individual high-spin
forms as well as their rhombicity and intensity fraction based on the
simulation. Again, a low-spin species could not be detected. Moreover,
with increasing chlorite concentrations the intensity at g = 4.3 in-
creased slightly (compare Fig. 3A and C) reﬂecting the release of non-
heme Fe(III).
Next we tested another member of the vertebrate peroxidase sub-
family [31], namely bovine LPO, in its interaction with chlorite.
Lactoperoxidase was also unable to utilize chlorite in MCD chlorination
(data not shown) andwas even faster inactivated by chlorite thanMPO.
The reaction between LPO and chloritewas again biphasic (Supplemen-
tal Fig. 1). Upon mixing of 1 μM ferric LPO with 100 μM chlorite at
pH 5.0, a rapid spectral transition occurred within the ﬁrst 20 ms
(isosbestic point at 425 nm), resulting in a decrease in absorbance of
the Soret band which was accompanied by a small red shift of the
Soretmaximum (Supplemental Fig. 1A). This fast transitionwas follow-
ed by a slower reaction leading to a further loss of absorbance in the
Soret region within 400 ms (Supplemental Fig. 1B). Interestingly, and
in contrast to MPO, this second transition showed an isosbestic point
at 448 nm before heme bleaching occurred. The loss of absorbance at
the Soret maximum and the charge transfer bands during hemeTable 1
EPR simulation parameters from individual high spin forms of MPO with chlorite (HS —
high-spin, R — rhombicity, I — relative intensity, E/D — rhombic to axial contribution).
HS compounds⁎ gxeff gyeff gzeff E/D R (%) I (%)
Ferric MPO HS1 5.000 6.660 1.945 0.040 12 94
HS2 5.700 6.300 1.995 0.013 4 6
Ferric MPO +
5-fold chlorite
HS1 4.100 7.650 1.945 0.079 22 4
HS2 5.000 6.880 1.945 0.040 12 50
HS3 5.750 6.200 1.998 0.006 3 45
HS4 5.890 6.050 1.998 0.003 1 2
Ferric MPO +
10-fold chlorite
HS1 4.100 7.650 1.945 0.079 22 8
HS2 5.000 6.880 1.945 0.040 12 5
HS3 5.750 6.200 1.998 0.006 3 84
HS4 5.890 6.050 1.998 0.003 1 4
⁎ Minimum number of high-spin compounds used for simulation.
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Fig. 4. Impact of ligands on the interaction of MPO and chlorite. (A) 2 μM ferric MPO was
preincubated with 10 mM cyanide prior to mixing with 500 μM chlorite (ﬁnal enzyme
concentration 1 μM) at pH 5.0. First spectrum collected after 1.3 ms (black) corresponds
to the low-spin complex of MPO. Even 10 s after mixing with chlorite no changes in the
spectral features were detected (gray spectrum). (B) 4 μM ferric MPO at pH 5.0 was pre-
incubatedwith 100mM chloride prior to mixing with 200 μM chlorite (ﬁnal enzyme con-
centration 2 μM) at pH5.0. First spectrumwas taken after 5ms (bold), subsequent spectra
at 163ms, 317ms, 592ms, 1.1 s, 2.1 s, 3.1 s, 4.1 s, 6.2 s and 10 s (gray spectrum). The inset
shows an enlargement of the visible region from 500 to 700 nm for the same reaction.
(C) Time trace at 430 nm (black) including single-exponential ﬁt (gray) for the reaction
in (B). (D) Plot of pseudo-ﬁrst-order rate constants versus chlorite concentration.
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range of 600–850 nm with two clear peaks with maxima at 650 nm
and 730 nm (Supplemental Fig. 1E).
Analysis of the time traces at 412 nm and double exponential
ﬁtting yielded bimolecular rate constants of 2 × 106 M−1 s−1 (fast
transition) and 7.7 × 104 M−1 s−1 (slower transition) at pH 5.0
(Supplemental Fig. 1C & D). Both rates were signiﬁcantly faster
compared to MPO. Again this reaction was pH dependent. At
pH 7.0 both rate constants were about one order of magnitude
lower (1.1 × 105 M−1 s−1 and 4 × 103 M−1 s−1, respectively).
3.2. Inﬂuence of cyanide and chloride onhemebleachingmediated by chlorite
Cyanide is known to bind directly to the Fe(III) center of heme per-
oxidases [32]. Ferric MPO (2 μM) was incubated with 10 mM cyanide
resulting in the formation of a low-spin complex, characterized by a
red shift of the Soret band of MPO to 455 nm and formation of a prom-
inent peak at 635 nm (black spectrum in Fig. 4A). Upon addition of chlo-
rite to the cyanide complex of MPO no spectral changes were observed
even at high chlorite concentrations and prolonged measurements
(Fig. 4A, gray trace, ﬁnal concentration 500 μM chlorite). No heme
bleaching was observed. This suggests that the presence of cyanide
hampers the attack of the heme iron and/or the prosthetic group by
chlorite.
Since chloride acts both as high-spin ligand and substrate of MPO
[33], we have also probed the effect of chlorite on the MPO-Cl− com-
plex. At pH 5.0 the spectrum of the latter shows a Soret maximum at
435 nm and a Q-band at 574 nm. Myeloperoxidase was incubated
with 100 mM chloride at pH 5.0 before chlorite was added. Fig. 4B
shows the spectral changes of the reaction between 2 μM MPO-
chloride complex and 200 μM chlorite. In contrast to cyanide the
presence of chloride did not protectMPO fromhemebleaching. Howev-
er, compared to native MPO clear differences were observed. The reac-
tion was slower and monophasic (Fig. 4C). The absence of a shoulder
at 455 nm as well as of an absorbance increase at 625 nm (compared
to Fig. 1A) suggests that the presence of chloride had an inﬂuence on
the velocity of the formation of the (high-spin) MPO-chlorite complex
but not on the ﬁnal heme degradation. The presence of chloride did
slow down binding of chlorite and the reaction lost its biphasic behav-
ior. Heme bleaching was still evident from the observed increase of
absorbance in the longwavelength range (600–850 nm). This hypothe-
sis is underlined by the fact that the rate constant of absorbance loss at
430 nm of 2.5 × 103 M−1 s−1 (Fig. 4D) corresponded well to the rate of
absorbance increase at 720 nm, i.e. 4.8 × 103 M−1 s−1 (see also Fig. 2C).
For HRP we could demonstrate, that chlorine dioxide (besides chlo-
rite) mediates Compound I formation [12]. By contrast, neither ferric
MPO nor ferric LPO reacted with chlorine dioxide at pH 5.0 and 7.0.
No heme bleaching was observed and the spectral features of both en-
zymes remained unchanged (data not shown).
3.3. Reactions of Compound I and Compound II ofMPO and LPOwith chlorite
In the next step the reaction of preformed MPO Compound I with
chlorite was investigated by multi-mixing stopped-ﬂow spectroscopy.
In contrast to ferric MPO, Compound I reacted very fast with chlorite
forming Compound II, which was further converted back to ferric MPO
(Fig. 5). Fig. 5A depicts the spectral changes of the reaction between
2 μM MPO Compound I and 20 μM chlorite at pH 5.0. Compound II
was formed rapidly (Soret maximum at 455 nm and a dominant peak
at 625 nm). The ﬁrst recorded spectrum 1.3 ms after mixing (black
bold spectrum) already showed a signiﬁcant amount of Compound II
and the reaction was completed within 15 ms (gray spectrum). From
the monophasic time traces at 455 nm a bimolecular rate constant of
1.2 × 107 M−1 s−1 was calculated (Fig. 5B and C). The rate decreased
with increasing pH, i.e. 1.7 × 106 M−1 s−1 at pH 7.0.Compound II was not stable but reacted back to ferric MPO depen-
dent on the chlorite concentration (Fig. 5D is a continuation of Fig. 5A)
within 700 ms (isosbestic points at 441 nm, 490 nm, 585 nm and
670 nm). Exact determination of the bimolecular rate constant was
not possible due to the fact that excess of chlorite immediately reacted
with any formed ferric enzyme resulting in heme bleaching. Estimated
values for Compound II reduction were 1.4 × 105 M−1 s−1 at pH 5.0
and 3 × 104 M−1 s−1 at pH 7.0, respectively.
Similarly, Compounds I and II of LPO were probed in their reactivity
with chlorite. Clear monophasic transitions (without heme bleaching
during these distinct redox transformations) were observed. Supple-
mental Fig. 2A shows the reaction between 2 μM Compound I and
5 μM chlorite to Compound II (Soret maximum at 428 nm and two
peaks at 536 nm and 566 nm) at pH 7.0. The bimolecular rate constant
was calculated to be 5.8 × 106 M−1 s−1 at pH 7.0. The spectral features
obtained in these reactions did not resemble a pure Compound II but did
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the reaction of Compound II with chlorite.
Finally, Compound II of LPO (pre-formed bymixing of 8 μMLPOwith
12 μM hydrogen peroxide and 40 μM tryptophan in the aging loop and
setting a delay time of 2 s) [34] was directly converted to ferric LPO by
chlorite with a rate constant of 4.4 × 104 M−1 s−1 at pH 7.0 (Supple-
mental Fig. 2B). However, as already observed with MPO, ferric LPO
was not formed completely as it reacted immediately with excess chlo-
rite leading to heme destruction.Fig. 6. Inhibition of chlorination activity of MPO by chlorite. Activity wasmonitored either
by APF chlorination ﬂuorimetrically (A), monochlorodimedon (MCD) chlorination spec-
trophotometrically (B, C) or bymonitoring hydrogen peroxide consumption polarograph-
ically (D). In (A) and (B) MPO was incubated with various concentrations of chlorite for
one minute and the reaction was started by adding hydrogen peroxide. In (C) and (D)
the reaction was started by adding native MPO to the reaction mixture. For detailed reac-
tion conditions see Material and methods.3.4. Impact of chlorite on the overall halogenation activity of MPO
As mentioned at the beginning, the system of MPO/chlorite (in con-
trast to HRP/chlorite) was not able to promote monochlorodimedon
chlorination, suggesting that hypochlorous acid was not formed or atleast could not leave the heme cavity or immediately reacted with the
heme or neighboring amino acids of the protein. Hypochlorous acid is
well known to mediate Compound I formation of MPO [35] as well as
to promote degradation of the heme group [36]. Thus, in order to ex-
clude a role of HOCl in the observed heme bleaching reaction mediated
by chlorite, we have probed the impact of 10mMmethionine on the in-
activation process. Methionine is small enough to enter the substrate
channel and it reacts very fast with HOCl [37]. However, with both
MPO and LPO, the presence of methionine did not prevent heme
bleaching (data not shown). Similarly addition of taurine, another
very efﬁcient trap for hypochlorous acid, showed no effect on the spec-
tral transitions.
Next, the inhibitory effect of chlorite on the chlorination activity of
MPOwas determined. At pH5.0 the effectwas investigated both spectro-
photometrically (monitoring the chlorination ofMCD to DCD at 290 nm)
and polarographically (monitoring consumption of hydrogen peroxide).
In order to exclude a possible impact of MCD as potential one-
electron substrate for MPO Compounds I and II on the reaction, the ef-
fect of chlorite was in addition determined ﬂuorimetrically (monitoring
the chlorination of APF at pH 7.4). The reactions were started by addi-
tion of either MPO or hydrogen peroxide, in the latter case MPO was
preincubated with chlorite for 1 min.
Independent of the method used the inhibitory effect was stronger
whenMPOwas preincubatedwith chlorite and the reactionwas started
with hydrogen peroxide. A concentration of ~15 μM of chlorite resulted
in a loss of 50% activity (Fig. 6A & B) when MPO was preincubated with
chlorite. When the reaction was started with native MPO much higher
concentrations of chlorite (40–50 μM)were necessary to obtain 50% in-
hibition (Fig. 6C & D). These observations underline that onlyMPO in its
ferric state is susceptible to degradation by chlorite. Similar to high-spin
(chloride) or low-spin (cyanide) ligands the substrate hydrogen perox-
ide binds to the sixth heme position and protects or at least delays inac-
tivation by chlorite.
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Chlorite-mediatedheme destruction could readily be detected by in-
gel activity heme staining after samples were run on a non-reducing
SDS-PAGE. Human MPO (10 μg) was mixed with increasing concentra-
tions of chlorite (Fig. 7A; lane 2–5: 0, 50, 200 and 500 μM chlorite, re-
spectively) at pH 5.0 and loaded on the gel followed by activity
staining. Addition of chlorite decreased the color development in a con-
centration dependent manner (Fig. 7A), prooﬁng the loss of active
heme.
On a separate gel the same amount of MPO and chlorite were run on
a non-reducing SDS-PAGE and stained by Coomassie (Fig. 7B).
Myeloperoxidase predominantly ran as a dimer (lane 2) but upon
mixing with chlorite a second protein band at ~14 kDa appeared,
which corresponds to the light chain of MPO. The more chlorite was
added to MPO, the more pronounced was this band (Fig. 7B; lanes
3–5). Additionally, diffuse protein bands with high molar masses were
formed (lane 5), indicating either protein aggregation or crosslinked
multimeric states of MPO.
For comparison, Fig. 7C depicts the SDS-PAGE of the same sample
preparations under reducing conditions [50 mM dithiothreitol (DTT)
was added to the samples]. Here, two prominent bands of MPO ap-
peared, corresponding to its heavy (60 kDa) and light chains (14 kDa).
No differences between untreated and chlorite-treated samples were
detected indicating that the chlorite dependent decrease in heme activ-
ity staining was not due to loss of protein.
To further evaluate the effect of chlorite on the secondary structure
composition of MPO CD spectroscopy in the far-UV region was per-
formed. Fig. 8A shows identical CD spectra of 2 μM native MPO (pH
5.0) and 2 μM MPO after treatment with 1 mM chlorite at 25 °C. The
CD spectra consisted of two minima at 208 and 222 nm, which are typ-
ical for a mainly α-helical structure. Even upon longer incubations of
MPO with this huge excess of chlorite (500-times) only a very slight
loss of ellipticity was observed. Obviously, chlorite did not have any im-
pact on the overall secondary structure composition of MPO at room
temperature.
Next we investigated the effect of chlorite on the heme ellipticity in
the Soret region at room temperature. FerricMPO showed a negative el-
lipticity with a minimum around 412 nm in the Soret region (Fig. 8B,
black line). Upon binding of moderate (20-times) excess of chlorite
the signal changed dramatically resulting in alteration of the sign of el-
lipticity (Fig. 8B, gray line). This indicates that (i) the heme was still170 
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Fig. 7. SDS-PAGE analysis of MPO incubated with chlorite. (A) Non-reducing SDS-PAGE. Bands
visualized by Commassie staining. (C) Reducing SDS-PAGE. Protein bandswere visualized by Co
lane 4, 10 μg MPO + 200 μM chlorite; and lane 5, 10 μg MPO+ 500 μM chlorite.attached to MPO under these conditions (free heme does not show an
CD signal) and (ii) that upon chlorite binding the interaction of the pros-
thetic group and its (asymmetric) protein environmentwas signiﬁcant-
ly modiﬁed [38]. By contrast, simultaneous measurements of the Soret
maximum at 430 nm by UV–vis spectroscopy showed an almost com-
plete loss of absorbance in this region (Fig. 8C).170 
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unfolding of MPO were performed. Fig. 9 shows the DSC proﬁle of
MPO in 100 mM phosphate buffer, pH 5.0. One slightly asymmetric en-
dotherm was obtained with a maximum at Tm of 87 °C. Deconvolution
of data suggests a non-two-state unfolding and two transitions at 84.5
and 87.5 °C. Upon incubation with a 5-time stoichiometric excess of
chlorite for 1min (stopping the reaction by 4mMcysteine) a complete-
ly different unfolding pattern was obtained that clearly reﬂected loss of
structural integrity and a diminished thermal stability. Satisfactory
ﬁtting was only possible by supposing of at least three intermediate
states with calculated Tm values at 87.5, 84.5 and 73.0 °C, respectively.
At longer incubation times or higher excess of chlorite, the Tm values
shifted to lower temperatures and the endotherms became broad and
ﬂat (data not shown).
3.6. Comparison of chloritewith chlorite-based drugs in interactionwithMPO
The drug substance OXO-K993 (NUVO Research Inc., Mississauga,
Canada), also referred as tetrachlorodecaoxygen anionic complex
[i.e. (Cl4O10)n with molar mass of 301.8 for n = 1] contains 4.25%
chlorite, 1.9% chloride, 1.5% chlorate, 0.7% sulfate and sodium ions
as cationic species in an aqueous solution [14]. A sterile, pyrogen-
free, aqueous 10% (w/v) solution of OXO-K993 is applied under the
name WF10 for intravenous infusion in patients with chronic-
inﬂammatory diseases [39–41]. Another 55-fold diluted formulation
derived from OXO-K993 is Oxoferin™ that is topically applied as a
wound-healing agent [42,43].
Here we applied Oxoferin to test the effects of this drug solution
upon interactionwithMPO. The chlorite content in Oxoferin is reported
to be 12.3 mM [44]. To test if the additives lead to any differences in re-
activity the direct reaction of human ferric MPO with this drug was in-
vestigated. The reaction of MPO with Oxoferin showed similar kinetics
and ﬁnally resulted in heme bleaching (Supplemental Fig. 3). The reac-
tion was biphasic with calculated rate constants of 3.9 × 105 M−1 s−1
and 2.3 × 104 M−1 s−1 (pH 5.0), respectively. Thus, with respect to re-
activity towardsMPO in terms of heme bleaching and kinetics, Oxoferin
is indistinguishable from a pure chlorite solution.
4. Discussion
In the present study, we have demonstrated remarkable differences
in the reaction of the mammalian peroxidases MPO and LPO withCp
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Fig. 9. Effect of chlorite on the thermostability of myeloperoxidase. Normalized DSC scans
of 5 μMMPO in the absence (lower panel) or presence of 25 μM chlorite in 100mM phos-
phate buffer, pH 5.0. Experimental data (black lines) and ﬁtting to non-two-state models
(gray lines) are shown.chlorite in comparison to the plant-type model peroxidase HRP. In the
latter, chlorite acts as both a two-electron oxidant for the ferric enzyme
forming Compound I as well as a one-electron donor for Compound I
and Compound II. Two reaction products are formed, hypochlorous
acid and chlorine dioxide, and both can mediate chlorination reactions.
By contrast, the system MPO/chlorite is unable to perform chlorination
reactions.
The main difference between the mammalian peroxidases and
HRP concerns the interaction of chlorite with the ferric resting
state. Chlorite is well known to oxidize ferric HRP to Compound I
by abstracting two electrons [12]. The standard reduction potential
for the couple Compound I/ferric HRP can be calculated from data
given in ref. [45] to be 0.92 V at pH 7. This value is lower than the po-
tential for the couple ClO2−/HOCl, H2O being 1.08 V at pH 7 [46], indi-
cating the thermodynamic feasibility of HRP oxidation by chlorite.
Under slightly acidic conditions, this oxidation becomes more favor-
able because of the divergent pH dependencies of both redox cou-
ples. The potential of the couple Compound I/ferric HRP increases
by 0.59 V per decreasing pH unit, while a corresponding increase of
0.88 V is found for the couple ClO2−/HOCl, H2O.
However, chlorite was unable to oxidize ferric LPO or MPO to Com-
pound I. Instead of this, both peroxidases were inactivated by chlorite
due to heme degradation. The standard reduction potentials of the
redox couple Compound I/ferric enzyme are higher than for HRP at pH
7 with 1.16 V for MPO [47] and 1.09 V for LPO [34]. Considering the
abovementioned pH dependencies of redox couples, an oxidation of at
least ferric LPO to Compound I by chlorite can be expected at lower
pH values. However, our results clearly revealed that even at pH 5 nei-
ther LPO nor MPO were oxidized by chlorite. Thus in addition, differ-
ences in the heme structure and the surrounding protein are
apparently responsible for divergent chlorite effects with ferric MPO
and LPO in contrast to ferric HRP. Themost striking structural difference
in the active site between HRP and the mammalian peroxidases is that
in the latter two the heme is covalently attached to the protein
(Fig. 10). The 1- and 5-methyl groups of heme pyrrole rings A and C
aremodiﬁed in both LPO andMPO allowing them to form ester linkages
with the carboxyl group of a conserved aspartate and glutamate. In ad-
dition, in MPO a sulfonium linkage between the ß-carbon of the vinyl
ring of pyrrole ring A and the sulfur atom of methionine 243 is formed
[15]. Besides these heme modiﬁcations also the residues on the distal
side of the hemediffer betweenHRP andMPO/LPO. In plant-type perox-
idases the triad histidine, arginine and phenylalanine is conserved,
whereas themost prominent distal residues inmammalian peroxidases
are histidine, arginine and glutamine, respectively (Fig. 10).
Chlorite rapidly binds at the active site forming a high-spin com-
plex (MPO: 4.6 × 104M−1 s−1 and LPO: 1.1 × 105 M−1 s−1 at pH 7.0)
as demonstrated by (i) UV–vis stopped-ﬂow spectroscopy, (ii) EPR-
spectroscopy, and (iii) the impact of cyanide and chloride on this
reaction. After binding of chlorite heme degradation occurred
(MPO: 1.5 × 103 M−1 s−1 and LPO: 4.0 × 103 M−1 s−1 at pH 7.0)
leading to loss of Soret absorbance and partial iron release. New ab-
sorbance bands in the region 600–800 nm indicate the formation of
heme degradation product(s). The pH-dependence of both reactions
(chlorite binding and heme bleaching) suggests that apparently
HOClO, the protonated form of chlorite, is the reactive species. The
pKa value of HOClO is 1.72 [48].
In contrast to the ferric state, Compounds I and II ofMPO and LPO are
able to oxidize chlorite in a one-electron step as was previously ob-
served for HRP [12]. However, rate constants for these transitions are
much higher for MPO and LPO than for HRP in the pH range from 4 to
7. For all three peroxidases, these rate constants increase with decreas-
ing pH. In addition to structural aspects determining the binding of
chlorite near the heme, thermodynamic considerations play also a role
in this divergent behavior. The standard reduction potential of the cou-
ple ClO2/ClO2− has a value of 0.934 V and is independent of pH at pH
values higher than 2 [49]. The reduction potential for the couple
Horseradish peroxidase (HRP) Bovine lactoperoxidase (LPO) Human myeloperoxidase (MPO)
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Fig. 10. Active site structure of HRP, bovine LPO and human MPO. The ﬁgures were constructed using the coordinates deposited in the Protein Data Bank. Accession codes: 1ATJ (HRP),
1CXP (MPO) and 2GJM (LPO).
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[12]. The corresponding E°′ values for MPO and LPO at pH 7 are signiﬁ-
cantly higher, namely 1.35 V [50] and 1.14 V [34], respectively,
reﬂecting better oxidation capacities for chlorite oxidation compared
to HRP. For the couples Compound II/ferric enzyme the E°' values for
MPO and LPO are 0.97 V [50] and 1.04 V [34], respectively, at pH 7.
These values are slightly higher than the corresponding value for HRP
being 0.93 V [12].
During one-electron oxidation of chlorite by Compound I/II chlorine
dioxide has to be formed as a reaction product. This was demonstrated
in the HRP-mediated transitions monitored by the increase of absor-
bance of ClO2 at 359 nm. In the MPO/chlorite or LPO/chlorite systems
ClO2 could not accumulate since the reaction cycle is interrupted at
the ferric state, which is immediately attacked by the excess of chlorite
resulting in heme bleaching. Thus, neither HOCl (two-electron reduc-
tion product of chlorite) nor sufﬁcient amounts of ClO2 (one-electron
oxidation product) could be formed which easily explains the absence
of chlorination activity. We could also demonstrate that ClO2 is unable
to mediate heme degradation upon addition to ferric MPO.
Upon interaction withMPO chlorite destroys the structural integrity
of MPO. Activity staining in SDS-PAGE, UV–vis- and EPR-spectroscopy
clearly demonstrated that chlorite causes heme degradation, partly by
release of free iron. Although the overall secondary composition of
MPO was not affected as determined by far-UV ECD spectroscopy, the
conformational and thermal stability was decreased and the light
chain detached from the protein in SDS-PAGE under non-reducing con-
ditions. This can easily be explained by the fact that in native MPO the
prosthetic group (together with a Ca2+-ion) crosslinks the light and
heavy chains [51]. Upon degradation of the prosthetic group the two
polypeptides fall apart under denaturing conditions.
Comparing effects of pure chlorite with the chlorite-containing drug
Oxoferin, we observed nearly identical kinetics of its interaction with
the relevant redox intermediates. Oxoferin also mediated heme
bleaching. Thus, concerning the interaction with heme in MPO, chlorite
is really an active compound in the OXO-K993-derived drug solution
Oxoferin. To what extent the interaction of the chlorite-containing
drugs Oxoferin and WF10 with MPO are responsible for the observed
therapeutic effects of these drugs, remains unknown. As shown here,
chlorite is able to inactivate MPO and LPO irreversibly with the ferric
state representing the susceptible redox intermediate. Inactivation in-
cluded heme degradation and iron release. Recently 2-thioxanthines
were also described as potent irreversible inactivators of MPO [52,53].
However, kinetic analysis, mass spectrometry and X-ray crystal struc-
tures revealed that these inhibitors become oxidized by MPO and,ﬁnally, covalently attached to the heme prosthetic groups thereby
blocking the entrance to the heme cavity. Being dependent on hydrogen
peroxide 2-thioxanthines are typical mechanism-based inhibitors,
whereas chlorite competes with H2O2 for binding to ferric MPO.
Data about potential chlorite actions under pathological conditions
like cardiovascular diseases, where MPO is known for their adverse
effects [54,55], are lacking. In therapeutic use, other possible chlorite
effects are modulation and stimulation of immune responses [56], acti-
vation of macrophage functions [40], the stimulation of killer cell cyto-
toxicity [57], methemoglobin formation [44] and formation of chlorine
dioxide. The later species has strong anti-microbial properties [58] and
can be also derived from one-electron oxidation of chlorite by Com-
pounds I and II of MPO or LPO. At inﬂammatory sites, the likelihood
for the aforementioned chlorite activity might be increased considering
enhanced levels of hydrogen peroxide at these sites. Taken together,
chlorite can principally cause a number of divergent effects upon its ap-
plication. Which effects under strong pathological conditions dominate
needs to be further speciﬁed.Abbreviations
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